Japanese
English
- 有料閲覧
- Abstract 文献概要
- 1ページ目 Look Inside
- 参考文献 Reference
抄録 持効性注射剤(LAI)は血中濃度を安定させることで統合失調症患者の治療に有効である。当院では2種類の持効性注射剤の併用療法を8例に行った。LAIの併用により内服薬のCP換算値は平均1,100.9から543.8と減量され,4例は抗精神病薬を内服しなかった。診療録で確認できる副作用はなく,抗パーキンソン病薬や下剤の併用も減少した。8例中7例は退院し,6例は再入院せずに地域で生活している。副作用の問題が大きく,すでに多剤併用療法になっており,ECTやclozapineが選択できないものなど対象は厳しく選ぶ必要があるが,併用療法が退院支援,地域生活を維持する上で有効である可能性が示唆された。
A long-acting antipsychotic(LAI) is effective in treating schizophrenic patients by stabilizing the blood level. The single LAI dose may be insufficient and may be combined with oral medication, but there is also a risk of recurrence due to low adherence. At our hospital, combination therapy of two types of sustained-release injections were given to 8 patients. The CP conversion value of the oral drug was reduced from an average of 1100.9 to 543.8 by the combined use of LAI, and 4 patients did not take the oral antipsychotic drug. Of the 8 cases, 7 were discharged and 6 were living in the community without being readmitted.
The problem of side effects is large, and the target is already high-dose multidrug therapy, and ECT and clozapine cannot be selected. It was suggested that the combination therapy may be effective in supporting discharge and maintaining community life.
Copyright © 2021, Igaku-Shoin Ltd. All rights reserved.